Vir Biotech gets U.S. funding for flu-prevention antibody
Go back to Vir Biotech gets U.S. funding for flu-prevention antibody| (NASDAQ: VIR) | Delayed: 9.78 +0.57 (6.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.21 | 52 Week High | $ | |||
| Open | $9.31 | 52 Week Low | $ | |||
| Day High | $9.86 | P/E | N/A | |||
| Day Low | $9.31 | EPS | $ | |||
| Volume | 1,756,470 | |||||

